Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2006 1
2007 1
2011 2
2012 5
2013 8
2014 5
2015 6
2016 6
2017 3
2018 2
2019 4
2020 3
2021 4
2022 3
2023 6
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Solodovnikova V, Liverko I, Moodliar R, Dodd M, Ngubane N, Rassool M, McHugh TD, Spigelman M, Moore DAJ, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL Study Collaborators. Nyang'wa BT, et al. Among authors: du cros p. N Engl J Med. 2022 Dec 22;387(25):2331-2343. doi: 10.1056/NEJMoa2117166. N Engl J Med. 2022. PMID: 36546625 Clinical Trial.
TB-PRACTECAL: study protocol for a randomised, controlled, open-label, phase II-III trial to evaluate the safety and efficacy of regimens containing bedaquiline and pretomanid for the treatment of adult patients with pulmonary multidrug-resistant tuberculosis.
Berry C, du Cros P, Fielding K, Gajewski S, Kazounis E, McHugh TD, Merle C, Motta I, Moore DAJ, Nyang'wa BT. Berry C, et al. Among authors: du cros p. Trials. 2022 Jun 13;23(1):484. doi: 10.1186/s13063-022-06331-8. Trials. 2022. PMID: 35698158 Free PMC article.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa BT, Berry C, Kazounis E, Motta I, Parpieva N, Tigay Z, Moodliar R, Dodd M, Solodovnikova V, Liverko I, Rajaram S, Rassool M, McHugh T, Spigelman M, Moore DA, Ritmeijer K, du Cros P, Fielding K; TB-PRACTECAL team. Nyang'wa BT, et al. Among authors: du cros p. Lancet Respir Med. 2024 Feb;12(2):117-128. doi: 10.1016/S2213-2600(23)00389-2. Epub 2023 Nov 16. Lancet Respir Med. 2024. PMID: 37980911 Free article. Clinical Trial.
Beyond the bubble: neighbours helping neighbours.
Lin YD, du Cros P, Greig J, Lavu EK, Hiasihri S. Lin YD, et al. Among authors: du cros p. Intern Med J. 2021 Jul;51(7):1013-1015. doi: 10.1111/imj.15416. Intern Med J. 2021. PMID: 34278685 No abstract available.
Global health action delayed: people's health and wellbeing denied.
Abrahams J, Armstrong F, Malunga C, du Cros P. Abrahams J, et al. Among authors: du cros p. Public Health Res Pract. 2024 Jun 19;34(2):3422411. doi: 10.17061/phrp3422411. Public Health Res Pract. 2024. PMID: 38889910 Free article. No abstract available.
Progress in Medicine: Experts Take Stock.
PLOS Medicine Editors; Beck A, Birney E, Graeber M, Tumwine J, Hay P, Ahn HS, Patel A, du Cros P, von Seidlein L, Wareham N, Low N. PLOS Medicine Editors, et al. Among authors: du cros p. PLoS Med. 2015 Dec 29;12(12):e1001933. doi: 10.1371/journal.pmed.1001933. eCollection 2015 Dec. PLoS Med. 2015. PMID: 26713445 Free PMC article.
WHO recommendations for multidrug-resistant tuberculosis.
Berry C, Achar J, du Cros P. Berry C, et al. Among authors: du cros p. Lancet. 2016 Nov 5;388(10057):2234. doi: 10.1016/S0140-6736(16)32071-2. Lancet. 2016. PMID: 27825500 No abstract available.
Bedaquiline overdose: A case report.
Telnov O, Alvarez V, Graglia E, Molfino L, du Cros P, Rich M. Telnov O, et al. Among authors: du cros p. Int J Infect Dis. 2019 Jul;84:138-140. doi: 10.1016/j.ijid.2019.03.035. Epub 2019 Apr 2. Int J Infect Dis. 2019. PMID: 30951878 Free article.
Treatment-resistant tinea caused by Trichophyton indotineae in Australia.
Chua KY, Halliday CL, Chen SC, Koning S, Pawlikowski J, du Cros P, Korman TM. Chua KY, et al. Among authors: du cros p. Med J Aust. 2024 Aug 19;221(4):192-194. doi: 10.5694/mja2.52386. Epub 2024 Jul 16. Med J Aust. 2024. PMID: 39013435 No abstract available.
63 results